Drug Database
PR

propranolol

✓ Approved

Bausch + Lomb Corporation · ADRB1 · 小分子

什么是 propranolol?

propranolol 是一种小分子,由Bausch + Lomb Corporation研发。该药已获批,用于治疗相关适应症,给药途径:Oral (PO)。

药物档案

公司Bausch + Lomb Corporation
药物类别小分子
分子靶点ADRB1, ADRB2
给药途径Oral (PO)
状态Approved

作用机制

分子靶点

propranolol 作用于 2 个分子靶点:

ADRB1adrenoceptor beta 1 (B1AR, RHR)
ADRB2adrenoceptor beta 2 (B2AR, ADRBR)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

propranolol 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Vascular disordersHypertension✓ Approved

相关研究文献

PubMedExperimental and molecular pathology2026-11-16

The apelin-APJ axis in infantile hemangioma: Emerging evidence and potential links to propranolol response.

Chen Qiang Q, Chen Meng M, Chen Bin B, Xie Yimin Y

Propranolol is the standard first-line systemic therapy for infantile hemangioma (IH), but its antiangiogenic mechanisms remain incompletely defined. Emerging evidence implicates the apelin-APJ system in IH endothelial biology. APJ is enriched in hemangioma-derived endothelial cells (HemECs), and pharmacological inhibition suppresses proliferation, migration and angiogenic behavior, with genetic experiments supporting an APJ-dependent component. Separately, propranolol reduces APLN transcription in IH-derived models, and circulating apelin declines during treatment. These findings motivate investigation of an indirect link through ligand regulation, but do not establish APJ-dependent mediation of propranolol efficacy. This review distinguishes ligand transcription, ligand abundance, receptor expression and receptor-dependent function, integrating IH observations with mechanistic evidence from other vascular and disease models. We examine endothelial cell states, HIF-1α-dependent transcription, and the distinct SOX18-mevalonate mechanism of R(+)-propranolol. Cross-disease intervention studies provide a rationale for investigating treatment responsiveness. Priorities include defining functional ligand sources and recipient cells, testing receptor-dependent effects on drug response, validating circulating biomarkers, and establishing developmental safety before therapeutic translation.

PMID 43038722
阅读全文 →
PubMedAcute medicine & surgery2026-11-15

Sympathetic Hyperactivity in the Recovery Phase of Severe Tetrodotoxin Poisoning: A Case Report.

Ishimura Kei K, Yoshino Tomomi T, Matoi Aisa A, Shigemitsu Kazuaki K

Tetrodotoxin poisoning can cause hypotension through peripheral sympathetic blockade. A case of paroxysmal tachycardia, hypertension, and fever suggestive of sympathetic hyperactivity during recovery from severe poisoning is reported. A woman in her 70s with hypertension developed respiratory arrest after eating pufferfish liver and required mechanical ventilation. Neurological recovery began on Day 4, accompanied by recurrent tachycardia, hypertension, and fever. Heart rate reached 154 bpm and temperature reached 40.2°C on Day 8. After propranolol initiation on Day 8, tachycardia and fever episodes lessened, although intermittent blood pressure elevations persisted. Propranolol was gradually tapered and discontinued on Day 23. She was discharged home on Day 50. Sympathetic hyperactivity may complicate neurological recovery from severe tetrodotoxin poisoning. Propranolol initiation was temporally associated with reduced tachycardia and fever, but the underlying mechanism and treatment effect are unclear.

PMID 43032539
阅读全文 →
PubMedInternational journal of molecular sciences2026-11-14

Long-Term Propranolol Treatment Induces Anxiolytic-like Effects and Alters Hypothalamic Noradrenergic, Serotonergic and GABAergic Neurotransmission.

Witczyńska Adrianna A, Fijałkowski Łukasz Ł, Blecharz-Klin Kamilla K, Ziętal Katarzyna K et al.

Propranolol is a non-selective β-adrenergic receptor antagonist widely used in cardiovascular medicine and anxiety-related conditions; however, its central neurochemical mechanisms remain incompletely understood. This study investigated the effects of long-term propranolol administration on anxiety-like behavior and hypothalamic neurotransmission in rats. Adult male Sprague-Dawley rats received propranolol in drinking water at doses of 1, 2.5, or 5 mg/kg b.w./day for 33 days. Behavioral effects were assessed using the Open Field Test (OF) and Elevated Plus Maze (EPM). Hypothalamic concentrations of amino acids, e.g., γ-aminobutyric acid (GABA) as well as monoamines, and their metabolites were determined by high-performance liquid chromatography with electrochemical detection (HPLC-ED). Long-term propranolol treatment induced a significant anxiolytic-like effect, reflected by increased exploration of open arms in the EPM, without affecting locomotor activity in the OF. Neurochemical analyses revealed a significant increase in hypothalamic GABA levels and a marked reduction in noradrenergic turnover, as indicated by decreased MHPG/NA ratios. Propranolol also increased hypothalamic serotonin concentrations, whereas dopaminergic turnover remained unchanged. These findings demonstrate that long-term propranolol administration produces neurochemical changes within the hypothalamus involving noradrenergic, serotonergic, and GABAergic signaling pathways. The results suggest that the anxiolytic-like effects of propranolol extend beyond β-adrenergic receptor blockade and may be mediated by coordinated modulation of multiple neurotransmitter systems involved in stress regulation and emotional processing. The study provides new evidence linking chronic propranolol exposure to selective hypothalamic neurochemical remodeling associated with reduced anxiety-like behavior.

PMID 43028003
阅读全文 →
PubMedThe journal of physiological sciences : JPS2026-11-14

Limited β-adrenergic modulation of axillary sweating during moderate-intensity exercise in healthy young adult men.

Wang Hui H, Takizawa Daishin D, Otsuka Junto J, Meng Lu L et al.

Although β-adrenergic modulation of axillary sweating has been hypothesized via apocrine and/or eccrine sweat glands, no human study has directly tested whether local β-adrenergic antagonism attenuates axillary sweating. Fifteen healthy young men received propranolol, a non-selective β-blocker, or saline by iontophoresis at the axilla before moderate-intensity cycling followed by higher-intensity exercise to exhaustion. The exercise increased plasma adrenaline concentration at the end of the protocol (P = 0.001), but propranolol did not alter sweat onset time (P = 0.309) or sweat rate compared with saline in the axilla (all P ≥ 0.091). A follow-up experiment confirmed that propranolol attenuated isoproterenol-induced β-adrenergic sweating compared with the control site (P = 0.011). These findings indicate that β-adrenergic receptors play a limited role in axillary sweating during the present exercise protocol leading to exhaustion, although these receptors are pharmacologically responsive in the axilla of healthy young men.

PMID 43025171
阅读全文 →
PubMedReproductive biology2026-11-12

Effects of propranolol administration on follicular growth and survival after ovarian autotransplantation in mice.

Dias Karine Sthéfany Serpa Amaral KSSA, Pereira Luiza Aparecida Ansaloni Chagas LAAC, de Freitas Larissa Aline LA, Ferreira Camila Stefane CS et al.

One option for preserving female fertility is ovarian transplantation. The subcutaneous transplantation has been considered most promising due to its intrinsic nature, while the transplantation to the kidney capsule has been used mostly in experimental conditions. In both transplantation sites, there is a massive follicle loss during the first days. The mTOR signaling pathway is important for follicular activation, and propranolol is described as an activator of this pathway. The objective was to evaluate the action of propranolol on folliculogenesis after transplantation. Female mice were ovariectomized, and their ovaries were subcutaneously transplanted (experiment I). Vehicle or propranolol (40 mg/kg) was administered, and their transplants were recovered and directed to morphofunctional analysis. In experiment II, the ovaries were transplanted under the kidney capsule. In experiment I, ovarian weight was higher in the 15-day propranolol group compared to the vehicle group. At 6 days, the propranolol group showed a higher percentage of transitional and secondary follicles; secondary and antral increased at 15 days, and transitional and primary follicles decreased at 24 days. At 15 days, the propranolol group showed an increased oocyte/follicle ratio in primary follicles and a reduced ratio in secondary follicles. In experiment II, there was a decrease in the percentage of atretic follicles in treated animals and an increase in the oocyte/follicle ratio of transitional follicles in the propranolol group. Propranolol administration stimulated follicular growth at both transplant sites, indicating a promising potential in fertility preservation.

PMID 43019801
阅读全文 →
PubMedZhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery2026-11-11

[Clinical characteristics and comprehensive management strategies for vestibular migraine and recurrent vertigo of childhood].

Guo Z Q ZQ, Shi S Y SY, Zhang X X, Chen J Y JY et al.

Objective: To investigate the clinical characteristics and audio-vestibular features of vestibular migraine of childhood (VMC), probable VMC (PVMC), and recurrent vertigo of childhood (RVC), to analyze factors influencing attack frequency and quality of life, and to preliminarily evaluate the effectiveness of comprehensive management. Methods: A retrospective cohort of 45 VMC, 16 PVMC, and 9 RVC cases were enrolled. Univariate and multivariate logistic regression analyses identified factors influencing high attack frequency (≥5 attacks/month). All patients received baseline treatment (lifestyle modification and management of comorbidities). Additional medications (topiramate, propranolol, or flunarizine) were selected based on attack frequency. Efficacy was assessed using visual analog scale (VAS) and the degree of life impact. Results: The manifestations of vertigo are diverse in VMC and PVMC, but uniform in RVC. The proportion of high attack frequency (46.7%) were significantly higher in the VMC group than that in the PVMC group (6.3%) and RVC group (0%). Cochlear symptoms were common, primarily tinnitus (27.1%) and hearing loss (17.1%). Hearing loss was mild to moderate, affecting low-, mid- and high-frequency hearing thresholds. Most patients exhibited central vestibular dysfunction, with the highest abnormality rate observed in the vestibular autorotation test (60%). Multivariate analysis revealed that high attack frequency was independently influenced by disease type, duration, and age at onset, and was the strongest predictor of reduced quality of life. Basic treatment combined with topiramate significantly improved VAS scores for dizziness and headache as well as the degree of life impact, followed by propranolol and flunarizine. Conclusion: Central vestibular dysfunction is a prominent feature in Chinese pediatric VMC/PVMC and RVC patients, with cochlear symptoms being common. Attack frequency is mainly influenced by disease type and disease duration, and the comprehensive management strategy based on attack frequency demonstrates clinical feasibility.

PMID 43010816
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多propranolol